PEER-REVIEW OF RISPERIDONE IN THE TREATMENT OF PATIENTS WITH CHRONIC-SCHIZOPHRENIA - A MULTI-NATIONAL, MULTICENTER, DOUBLE-BLIND, PARALLEL-GROUP STUDY VERSUS HALOPERIDOL
The following assessments represent two reviewers' comments on both the original and revised versions of the paper by J. Peuskens on behalf of the Risperidone Study Group. The reviewers were originally anonymous. The responses to the assessments, from J. Peuskens on behalf of the Risperidone Study Group, follow the reviewers comments.